AlohaDan--I am starting to get interested in VSGN. I am a little perplexed by the MOA of Cellcade; I haven't read the papers yet but the results in small studies are quite impressive. I was particularly struck by the CHF results.
I am a little worried about the PAD. Although there was a substantial percentage difference between the two groups in the P2, the difference was not significant in the ITT group. Could be just because of a small sample size.
Market Data 
Markets 
AI
